GRDX GridAI Technologies Corp. Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
GRDX
—
—
Key stats
Related
About
- Industry (SIC)
- ELECTRIC & OTHER SERVICES COMBINED (4931) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 2
- List Date
- 2016-10-11
- CIK
- 0001604191
- Next Earnings
- 2026-11-18
- Headquarters
- Boca Raton, FL
- Homepage
- https://www.enterothera.com
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '25 | '26 | Avg |
|---|---|---|---|
| Jan | -- | -39.11% | -39.11% |
| Feb | -- | -26.52% | -26.52% |
| Mar | -- | -24.34% | -24.34% |
| Apr | -- | 1.21% | 1.21% |
| May | -- | 122.62% | 122.62% |
| Jun | -- | -31.03% | -31.03% |
| Jul | -- | -35.27% | -35.27% |
| Aug | -- | 27.84% | 27.84% |
| Sep | -- | 2.85% | 2.85% |
| Oct | -- | 61.34%* | 61.34% |
| Nov | -- | -- | -- |
| Dec | 87.90% | -- | 87.90% |
| Total | 87.90% | -27.76% | 30.07% |
* Only 2 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $4.44
SMA 50: $3.87
SMA 200: $3.49
Current: $5.55
EMA 12: $4.86
EMA 26: $4.41
MACD: 0.4527 | Signal: 0.1141
BULLISH
ADX (14): 34.29
TREND
+DI: 29.26
−DI: 8.24
Momentum Oscillators
RSI (14): 69.54
NEUTRAL
Stoch %K: 94.97
Stoch %D: 90.73
Williams %R: -9.76
Volume & Volatility
BB Upper: $5.74
BB Lower: $3.14
NEUTRAL
OBV: 3,306,011
Vol SMA 20: 109,229
Vol ROC: 78.99%
ATR: $0.50
True Range: $0.50
HV 20: 109.6%
HV 30: 105.7%
HV 60: 102.7%
Data Summary
Data Points: 227
Last Updated:
Date Range: 2025-12-01T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: GRDX
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 6/10) Key Drivers: High volatility, negative momentum signals, and lack of recent news sentiment impact. Primary Risks: Trend reversal, increasing volatility, and potential technical breakdown.
2-3 Sentence Investment Thesis: GRDX is a high-risk stock with a bearish bias due to its high volatility, negative momentum signals, and the absence of recent positive news. While it has shown some resilience in the short term, the lack of upside momentum and the risk of trend reversal or technical breakdown pose significant risks for investors.
Recent News Sentiment Impact: No recent news headlines available, which reduces the confidence in this assessment.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): BEARISH, Medium-term (1-3 months): NEUTRAL, Long-term (3-12 months): BULLISH
Support/Resistance Levels: * Lower: $4.19 (Bollinger Band support) * Middle: $5.54 (SMA 20 and EMA 12 support)
Momentum Signals: * RSI interpretation: NEUTRAL (46.00) - not oversold or overbought * MACD signal: BULLISH (0.48) - momentum is increasing, but the signal line has not yet crossed above the histogram. * Bollinger Bands position: NEUTRAL - price is within the middle band.
Volume Analysis: Volume trends suggest institutional interest in GRDX, with a moderate increase in volume over the past month.
News & Sentiment Analysis
Recent Headlines Summary: No recent news headlines available. Sentiment Assessment: NEUTRAL (no recent news sentiment impact). Catalyst Identification: No upcoming events or earnings announcements to drive the stock price.
Market Narrative: The lack of recent news and negative momentum signals suggests that GRDX is driven more by technical factors than fundamental analysis.
Risk & Volatility Assessment
Beta Interpretation: HIGH RISK (beta 1.80) - stock moves more than the market. Volatility Regime: HIGH VOLATILITY - increasing volatility in recent months. Options Market Signals: No options data available. Downside Protection: Lower support at $4.19 and middle resistance at $5.54.
Market Context & Positioning
Sector Performance: GRDX has underperformed its sector peers over the past month. Institutional Activity: Moderate institutional interest in recent months, suggesting a potential increase in buying pressure. Correlation Analysis: R-squared analysis suggests that GRDX is not strongly correlated with the market.
Relative Valuation: GRDX is trading within its historical range and has not deviated significantly from its mean price.
Key Levels & Action Items
Critical Price Levels: * Lower support: $4.19 (Bollinger Band support) * Middle resistance: $5.54 (SMA 20 and EMA 12 support)
Breakout/Breakdown Levels: No significant technical levels to monitor.
Time-Sensitive Catalysts: No upcoming events or earnings announcements that could drive the stock price.
Risk Management: Stop-loss levels should be set at around $4.50, with position sizing considerations based on risk tolerance and market conditions.
Generated
News
All GRDX news →
GRDX Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.8588
Alpha: 140.15%
Correlation: 0.1860
R-Squared: 3.5%
Stock Volatility: 125.7%
Market Volatility: 12.6%
Analysis Details
Benchmark: SPY
Data Points: 226
Period: 252 trading days
Data Points: 226
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own GRDX
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $827K | #2400 of 3138 | -4.1% | 13F | |
| Citadel Hedge fund Ken Griffin | $400K | #4737 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
GRDX Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
GRDX Insider Trading (Form 4)
Latest: 2026-10-09Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Jason David Sawyer | Chief Executive Officer | Award (A) | +250,000 | — | EDGAR | |
| 2026-07-01 | Jason David Sawyer | Chief Executive Officer | Award (A) | +500,000 | — | EDGAR | |
| 2026-06-03 | Jack Syage | Director | Award (A) | +40,000 | — | EDGAR | |
| 2026-01-08 | Edward Borkowski | Director | Award (A) | +40,000 | — | EDGAR | |
| 2026-01-05 | Geordan Garrett Pursglove | Director | Award (A) | +40,000 | — | EDGAR | |
| 2026-01-05 | Manpreet Uppal | Director | Award (A) | +40,000 | — | EDGAR | |
| 2025-12-29 | Jason David Sawyer | Chief Executive Officer | Award (A) | +40,000 | — | EDGAR | |
| 2025-12-29 | Anna Skowron | Interim CFO | Award (A) | +65,000 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
GRDX Insider Holdings
6 insiders · @ $5.55
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jason David Sawyer | Chief Executive Officer | 790,000 | $4.38M | $0 | 3 | 2026-10-09 |
| 2 | Anna Skowron | Interim CFO | 65,000 | $360.8K | $0 | 1 | 2025-12-29 |
| 3 | Edward Borkowski | Director | 60,248 | $334.4K | $0 | 1 | 2026-01-08 |
| 4 | Jack Syage | Director | 40,000 | $222.0K | $0 | 1 | 2026-06-03 |
| 5 | Manpreet Uppal | Director | 40,000 | $222.0K | $0 | 1 | 2026-01-05 |
| 6 | Geordan Garrett Pursglove | Director | 40,000 | $222.0K | $0 | 1 | 2026-01-05 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
GRDX Board & Officers
As of SEC filings through Oct 9, 2026Directors 5
- Edward Borkowski · since Oct 11, 2016
- Jack Syage · since Mar 13, 2024
- Manpreet Uppal · since Feb 3, 2025
- Geordan Garrett Pursglove · since Aug 11, 2025
- Jason David Sawyer · since Aug 11, 2025
Officers 2
- Jason David Sawyer · Chief Executive Officer · listed since Dec 2025
- Anna Skowron · Interim CFO · since Mar 7, 2025
Changes in the last 10 years (41)
| Dec 29, 2025 | Jason David Sawyer first listed as Chief Executive Officer in an SEC filing |
| Nov 28, 2025 | The company announced the departure of Eric Corbett from the board in an SEC filing |
| Aug 11, 2025 | Jason David Sawyer became a director |
| Aug 11, 2025 | Geordan Garrett Pursglove became a director |
| Mar 7, 2025 | Anna Skowron became Interim CFO |
| Mar 3, 2025 | The company announced the departure of Sarah Romano as Chief Financial Officer in an SEC filing |
| Feb 12, 2025 | The company announced the departure of Richard Paolone from the board in an SEC filing |
| Feb 5, 2025 | Eric Corbett became a director |
| Feb 3, 2025 | Richard Paolone became a director |
| Feb 3, 2025 | Richard Paolone became Interim CEO |
| Feb 3, 2025 | Manpreet Uppal became a director |
| Jan 31, 2025 | The company announced the departure of Timothy R. Ramdeen from the board in an SEC filing |
| Jan 31, 2025 | The company announced the departure of James Sapirstein from the board in an SEC filing |
| Jan 31, 2025 | The company announced the departure of Alastair Riddell from the board in an SEC filing |
| Aug 16, 2024 | The company announced the departure of Chaitan Phd Khosla from the board in an SEC filing |
| Aug 9, 2024 | Timothy R. Ramdeen became a director |
| Aug 2, 2024 | The company announced the departure of Mary Theresa Coelho from the board in an SEC filing |
| Aug 2, 2024 | The company announced the departure of Charles J Casamento from the board in an SEC filing |
| Mar 19, 2024 | James Sapirstein listed as Chairman and CEO (previously Chairman, President and CEO) in SEC filings |
| Mar 13, 2024 | Jack Syage became a director |
| Mar 13, 2024 | Jack Syage became President & COO |
| Mar 13, 2024 | Chaitan Phd Khosla became a director |
| Jan 3, 2024 | James Sapirstein listed as Chairman, President and CEO (previously President and CEO) in SEC filings |
| Jan 5, 2023 | James Sapirstein listed as President and CEO (previously Pres, CEO & Chairman of Board) in SEC filings |
| Jun 16, 2022 | The company announced the departure of Gregory Oakes from the board in an SEC filing |
| Apr 27, 2022 | David Andrew Hoffman became a director |
| Mar 31, 2022 | The company announced the departure of James Pennington as Chief Medical Officer in an SEC filing |
| Mar 1, 2022 | Sarah Romano became Chief Financial Officer |
| Feb 14, 2022 | The company announced the departure of Daniel H Schneiderman as Chief Financial Officer in an SEC filing |
| Nov 4, 2021 | The company announced the departure of Vern Lee Schramm from the board in an SEC filing |
| Aug 11, 2021 | Mary Theresa Coelho became a director |
| Jul 2, 2021 | James Sapirstein listed as Pres, CEO & Chairman of Board (previously President and CEO) in SEC filings |
| Apr 13, 2020 | Gregory Oakes became a director |
| Jan 29, 2020 | Edmund Burke Ross Jr. reported in an SEC filing no longer being a 10% owner |
| Jan 2, 2020 | Daniel H Schneiderman became Chief Financial Officer |
| Oct 8, 2019 | James Sapirstein became a director |
| Oct 8, 2019 | James Sapirstein became President and CEO |
| May 29, 2018 | James Pennington became Chief Medical Officer |
| Oct 10, 2017 | Vern Lee Schramm became a director |
| Sep 27, 2017 | Maged Shenouda first listed as Chief Financial Officer in an SEC filing |
| Mar 3, 2017 | Charles J Casamento became a director |
Not reported recently (8)
- Richard Paolone · Last reported as Interim CEO in an SEC filing dated Feb 13, 2025
- James Sapirstein · Last reported as Chairman and CEO in an SEC filing dated Jul 3, 2024
- David Andrew Hoffman · Last reported as a director in an SEC filing dated Jan 5, 2023
- Johan M. Spoor · Last reported as a director in an SEC filing dated Apr 7, 2020
- Maged Shenouda · Last reported as a director in an SEC filing dated Jan 2, 2019
- Daniel Dupret · Last reported as Chief Scientific Officer in an SEC filing dated Jul 18, 2018
- Matthew Balk · Last reported as a 10% owner in an SEC filing dated Jul 5, 2017
- Pelican Partners LLC · Last reported as a 10% owner in an SEC filing dated Jul 5, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
GRDX Proposed Insider Sales (Form 144)
Latest: 2023-09-15
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | Charles Casamento | Director | 10 | $4 | 2023-09-15 | UBS Financial Services Inc | — | EDGAR |
| 2023-09-07 | Charles J. Casamento | Director | 6,053 | $1.8K | 2023-08-31 | Morgan Stanley | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
2 ETFs hold GRDX
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.